Ernexa Therapeutics Inc. Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent
Ernexa Therapeutics Inc. (ERNA) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent of $40.00 thousand as of 2021-12-31, per its 10-K/A filed 2022-07-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense › Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent · last filed 2022-07-01
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent $40.00K.
- 2020-12-31: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent $0.00.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent |
|---|---|
| 2021-12-31 | $40.00K 10-K/A · filed 2022-07-01 |
| 2020-12-31 | $0.00 10-K/A · filed 2022-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |